tizanidine
Generic: tizanidine
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
tizanidine
Generic Name
tizanidine
Labeler
asclemed usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
tizanidine hydrochloride 2 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-885
Product ID
76420-885_2a395a10-4c73-4213-e063-6394a90abb25
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208187
Listing Expiration
2026-12-31
Marketing Start
2021-03-04
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420885
Hyphenated Format
76420-885
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tizanidine (source: ndc)
Generic Name
tizanidine (source: ndc)
Application Number
ANDA208187 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/1
Packaging
- 1000 TABLET in 1 BOTTLE (76420-885-00)
- 100 TABLET in 1 BOTTLE (76420-885-01)
- 10 TABLET in 1 BLISTER PACK (76420-885-11)
- 15 TABLET in 1 BOTTLE (76420-885-15)
- 150 TABLET in 1 BOTTLE (76420-885-21)
- 30 TABLET in 1 BOTTLE (76420-885-30)
- 60 TABLET in 1 BOTTLE (76420-885-60)
- 10 TABLET in 1 BOTTLE (76420-885-88)
- 90 TABLET in 1 BOTTLE (76420-885-90)
- 10 BLISTER PACK in 1 CARTON (76420-885-99) / 10 TABLET in 1 BLISTER PACK
Packages (10)
76420-885-00
1000 TABLET in 1 BOTTLE (76420-885-00)
76420-885-01
100 TABLET in 1 BOTTLE (76420-885-01)
76420-885-11
10 TABLET in 1 BLISTER PACK (76420-885-11)
76420-885-15
15 TABLET in 1 BOTTLE (76420-885-15)
76420-885-21
150 TABLET in 1 BOTTLE (76420-885-21)
76420-885-30
30 TABLET in 1 BOTTLE (76420-885-30)
76420-885-60
60 TABLET in 1 BOTTLE (76420-885-60)
76420-885-88
10 TABLET in 1 BOTTLE (76420-885-88)
76420-885-90
90 TABLET in 1 BOTTLE (76420-885-90)
76420-885-99
10 BLISTER PACK in 1 CARTON (76420-885-99) / 10 TABLET in 1 BLISTER PACK
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2a395a10-4c73-4213-e063-6394a90abb25", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["a9ba9023-0c3f-4c9b-ba8e-d39d23bf35d6"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76420-885-00)", "package_ndc": "76420-885-00", "marketing_start_date": "20241227"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-885-01)", "package_ndc": "76420-885-01", "marketing_start_date": "20241227"}, {"sample": false, "description": "10 TABLET in 1 BLISTER PACK (76420-885-11)", "package_ndc": "76420-885-11", "marketing_start_date": "20241227"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (76420-885-15)", "package_ndc": "76420-885-15", "marketing_start_date": "20241227"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (76420-885-21)", "package_ndc": "76420-885-21", "marketing_start_date": "20241227"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-885-30)", "package_ndc": "76420-885-30", "marketing_start_date": "20241227"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-885-60)", "package_ndc": "76420-885-60", "marketing_start_date": "20241227"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (76420-885-88)", "package_ndc": "76420-885-88", "marketing_start_date": "20241227"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-885-90)", "package_ndc": "76420-885-90", "marketing_start_date": "20241227"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (76420-885-99) / 10 TABLET in 1 BLISTER PACK", "package_ndc": "76420-885-99", "marketing_start_date": "20241227"}], "brand_name": "tizanidine", "product_id": "76420-885_2a395a10-4c73-4213-e063-6394a90abb25", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "76420-885", "generic_name": "tizanidine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA208187", "marketing_category": "ANDA", "marketing_start_date": "20210304", "listing_expiration_date": "20261231"}